Top 30 Companies in Proteomics Market (2025–2035): Competitive Analysis and Forecast
RELEASE DATE: Sep 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Proteomics Market Size is projected to Grow from USD 27.65 Billion in 2024 to USD 104.20 Billion by 2035, at a CAGR of 12.82% during the forecast period 2025–2035. The market for proteomics is in greater demand as advancements in mass spectrometry, rising demand for personalized medicine, and increasing government and private investment in life sciences.
Introduction
Proteomics is the large-scale study of proteins, including their structures and activities, which is critical for understanding biological systems, disease processes, and treatment development. The worldwide proteomics market is expanding steadily due to advances in high-throughput technology, mass spectrometry, and bioinformatics tools that allow for exact protein identification and quantification. The growing desire for personalized medicine and targeted medicines is fueling adoption, since proteomics provides useful insights for biomarker identification and medication development. Pharmaceutical and biotechnology businesses are expanding their investments in proteomics to speed up research and enhance clinical outcomes, while academic institutions continue to investigate its uses in disease biology and diagnosis. The rising incidence of chronic illnesses such as cancer, cardiovascular disease, and neurological disorders has increased the demand for early diagnosis and new therapies, driving market growth. Furthermore, cooperation between academic institutions and industry participants is expediting the development and commercialization of proteomics-based solutions. The U.S. market is particularly substantial, due to robust R&D infrastructure, modern healthcare systems, and supportive government financing, making it a crucial contributor to worldwide proteomics progress.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Proteomics Market.
Proteomics Market Size & Statistics
- The Market Size for Proteomics Market Was Estimated to be worth USD 27.65 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 12.82% between 2025 and 2035.
- The Global Proteomics Market Size is anticipated to reach USD 104.20 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Proteomics Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Proteomics Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Proteomics Market. Asia Pacific is expected to grow at the fastest pace in the proteomics market, driven by increasing chronic disease prevalence, growing outsourcing of proteomics projects, supportive funding, favorable regulations, and the strong presence of biotechnology and biopharmaceutical companies.
North America is expected to generate the highest demand during the forecast period in the Proteomics Market. North America leads the proteomics market due to technological advancements, rising demand for advanced diagnostics, and strong investments in precision medicine. Supportive government funding, extensive biotechnology research, and a highly developed healthcare infrastructure further strengthen the region’s dominant position.
Top 10 Trends in the Proteomics Market
- Personalized Medicine & Biomarker Discovery
- AI and Machine Learning Integration
- Single-Cell and Spatial Proteomics
- Advancements in Mass Spectrometry
- Multi-Omics Approaches
- High Investments in R&D
- Enhanced Drug Discovery
- Collaboration and Partnerships
- Focus on Clinical Diagnostics
- Automation and Throughput
1. Personalized Medicine & Biomarker Discovery
Proteomics is important in personalized medicine because it identifies protein biomarkers that aid in illness diagnosis, treatment outcome prediction, and medication efficacy monitoring. The increasing emphasis on precision healthcare is driving demand for proteomics-based biomarker discovery.
2. AI and Machine Learning Integration
Artificial intelligence and machine learning are rapidly being utilized in proteomics to analyse vast and complicated protein datasets. These technologies improve accuracy, accelerate discovery, and enable advanced applications, including illness prediction, drug target identification, and therapy optimization.
3. Single-Cell and Spatial Proteomics
Single-cell and spatial proteomics allow researchers to analyze proteins at the individual cell level while also understanding their spatial distribution inside tissues. This advancement increases understanding of disease pathways, tumor heterogeneity, and immune responses, hence expanding applications in diagnostics and therapeutic development.
4. Advancements in Mass Spectrometry
Mass spectrometry is always improving, with better sensitivity, faster throughput, and more precise protein identification. These advancements boost proteomics applications in clinical diagnostics, biomarker validation, and pharmaceutical research, contributing to the market's technical growth.
5. Multi-Omics Approaches
The combination of proteomics, genomes, transcriptomics, and metabolomics yields a comprehensive knowledge of biological systems. Multi-omics techniques expedite precision medicine, drug discovery, and disease pathway analysis, making them a game-changer in healthcare and biotechnology research.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the proteomics market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Proteomics Market
- Illumina, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- F. Hoffmann-La Roche Ltd.
- Waters Corporation
- Merck KGaA
- Danaher
- Standard BioTools Inc.
- Bruker Corporation
- Revvity
- Shimadzu Corporation
- Promega Corporation
- Erofins
- QIAGEN
- Charles River Laboratories
- Protagene
- Perkin Elmer Inc.
- Horiba Ltd.
- Li-Cor Inc.
- Cell Signaling Technology, Inc.
- Beckman Coulter, Inc.
- Quantum-Si Incorporated
- BGI Group
1. Illumina, Inc.
Headquarters: San Diego, California, United States
Illumina is a global leader in life sciences tools and genomic technology, particularly its next-generation sequencing (NGS) systems. In the proteomics sector, the firm is critical in linking genomes and proteomics research to improve scientific discoveries. Its innovations provide a greater understanding of biomarker development, precision medicine, and enhanced disease diagnostics. Illumina advances tailored healthcare solutions by combining large-scale genomic and proteomic data. The organization partners with research institutes, biotechnology corporations, and clinical laboratories all over the world, with a strong operating presence in North America, Europe, and Asia, to promote global scientific and medical developments.
2. Agilent Technologies, Inc.
Headquarters: Santa Clara, California, United States
Agilent offers analytical equipment, software, and services for the life sciences, diagnostics, and applied applications, with a particular focus on proteomics. The firm provides powerful mass spectrometry instruments, fast sample preparation tools, and bioinformatics platforms that allow for accurate protein identification, quantification, and biomarker development. Agilent helps researchers investigate complicated protein activities, advance disease diagnostics, and drive precision medicine by using cutting-edge technology. Its solutions are extensively used in academic institutions, clinical laboratories, and the industrial sector, allowing for high-quality proteomics research across the world. With a global footprint, Agilent is a vital facilitator of innovation in life sciences and healthcare developments.
3. BIO-RAD LABORATORIES, INC.
Headquarters: Hercules, California, United States
Bio-Rad is a top provider of life science research and clinical diagnostics solutions, with a particular emphasis on proteomics. Its products include protein electrophoresis systems, western blotting platforms, imaging solutions, and multiplex assays, all of which are intended to help with comprehensive protein analysis and disease research. These tools help scientists and doctors better understand protein functions, identify biomarkers, and advance therapy development. Bio-Rad technologies are extensively used in research institutes, hospitals, and biotechnology enterprises, assuring high-quality findings and consistent performance. With a strong international presence, the firm continues to push innovation and promote proteomics research on a global scale.
4. Thermo Fisher Scientific, Inc.
Headquarters: Waltham, Massachusetts, United States
Thermo Fisher is a global leader in scientific services and technology, with a significant presence in the proteomics sector. The firm offers high-resolution mass spectrometers, sophisticated chromatography systems, and specialised reagents for large-scale protein research, biomarker identification, and clinical diagnostics. Its technologies help scientists analyze complicated proteomes, discover disease indicators, and advance precision medicine. Thermo Fisher's technologies are widely used by research institutes, biopharmaceutical businesses, and healthcare organizations to improve the accuracy, efficiency, and reliability of proteome investigations. With a global footprint, the organization continues to push innovation and contribute to advances in life sciences and healthcare.
5. Bruker Corporation
Headquarters: Billerica, Massachusetts, United States
Bruker specializes in high-performance scientific instruments and systems, with a strong focus on proteomics. The firm provides mass spectrometry instruments, NMR spectroscopy, and sophisticated analytical platforms that enable detailed protein characterization, structural biology research, and clinical proteomics applications. Its tools allow researchers to study complicated protein structures, find biomarkers, and make advances in drug discovery and illness diagnosis. Bruker is widely used in university institutions, biotechnology corporations, and pharmaceutical industries to assist both fundamental and applied proteomics research. With a large worldwide footprint that includes Europe, Asia, and other countries, the firm continues to promote innovation and deliver important tools to the life sciences community.
Are you ready to discover more about the proteomics market?
The report provides an in-depth analysis of the leading companies operating in the global proteomics market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Illumina, Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Agilent Technologies, Inc.
- BIO-RAD LABORATORIES, INC.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- F. Hoffmann-La Roche Ltd.
- Waters Corporation
- Merck KGaA
- Danaher
- Others.
Conclusion
The Global Proteomics Market Size is expanding rapidly, driven by increased demand for customized treatment, biomarker discovery, and enhanced disease diagnostics. Mass spectrometry, bioinformatics, and multi-omics advancements are allowing for more in-depth protein analysis, hence boosting precision medicine and pharmaceutical development. Key market players like Illumina, Agilent, Bio-Rad, Thermo Fisher, and Bruker are constantly developing to provide high-performance solutions for research, clinical, and industrial applications. The growing use of proteomics in medication development, clinical trials, and illness research emphasizes its importance in modern healthcare. Overall, the market's growth demonstrates the rising relevance of proteomics in understanding biological systems and improving patient outcomes worldwide.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?